Analysis of vascularity of human neurofibromas - 09/09/11
Abstract |
Background: A common misperception is that the vascularity of a tumor can be determined by its gross appearance. Neurofibromas are grossly white in appearance. The degree of vascularity of neurofibromas has not been determined. Objective: The purpose of this study was to determine the extent of neovascularization of neurofibromas. Methods: Neurofibromas from patients with neurofibromatosis-1 or spontaneous neurofibromas were stained with antibodies against von Willebrand factor (factor VIII–related antigen) and vascular endothelial growth factor (VEGF). Results: Neurofibromas, both spontaneous and congenital, exhibit a high degree of vascularity. In addition, perivascular cells in neurofibromas stain with antibodies to VEGF, an angiogenic factor. Conclusion: Neurofibromas, despite their gross appearance, are highly vascular. Their vascularity may be mediated, in part, through the angiogenic factor VEGF. (J Am Acad Dermatol 1998;39:950-4.)
Le texte complet de cet article est disponible en PDF.Plan
| ☆ | Supported in part by a Howard Hughes Postdoctoral Fellowship (to J. L. A.) and a grant from the Society for Pediatric Dermatology (to J. L. A.), the KAO Corporation Thomas B. Fitzpatrick Research Award (to J. L. A.), National Institutes of Health grant RO3AR44947 (to J. L. A.), and a Dermatology Foundation Clinical Career Development Award (to J. L. A.). |
| ☆☆ | Reprint requests: Jack L. Arbiser, MD, PhD, Emory University School of Medicine, Dept. of Dermatology, WMB 5th Floor, 1639 Pierce Dr., Atlanta, GA 30322. |
| ★ | 0190-9622/98/$5.00 + 0 16/1/90113 |
Vol 38 - N° 6
P. 950-954 - juin 1998 Retour au numéro
Article précédent
- Sparfloxacin-induced photosensitivity and the occurrence of a lichenoid tissue reaction after prolonged exposure
- Hiroko Hamanaka, Hitoshi Mizutani, Masayuki Shimizu
- Efficacy of pentoxifylline in the treatment of pruritic papular eruption of HIV-infected persons
- Brian Berman, Francisco Flores, George Burke
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?